Spirometry, DLCO, lung volumes and PET/CT findings after completion of tuberculosis treatment - preliminary findings of the StatinTB trial
K. Wolmarans (Cape Town, South Africa), S. Mukasa (Cape Town, South Africa), A. Mashinyira (Cape Town, South Africa), P. Katoto (Cape Town, South Africa), F. Jakoet-Bassier (Cape Town, South Africa), T. Kotze (Cape Town, South Africa), R. Guler (Cape Town, South Africa), G. Gunther (Bern, Switzerland), F. Thienemann (Zurich, Switzerland)
Source: International Congress 2022 – Epidemiological assessments and public health studies on tuberculosis and NTM
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Wolmarans (Cape Town, South Africa), S. Mukasa (Cape Town, South Africa), A. Mashinyira (Cape Town, South Africa), P. Katoto (Cape Town, South Africa), F. Jakoet-Bassier (Cape Town, South Africa), T. Kotze (Cape Town, South Africa), R. Guler (Cape Town, South Africa), G. Gunther (Bern, Switzerland), F. Thienemann (Zurich, Switzerland). Spirometry, DLCO, lung volumes and PET/CT findings after completion of tuberculosis treatment - preliminary findings of the StatinTB trial. 1904
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|